The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2011-12-01
|
| Col·lecció: | Oncology Reviews |
| Matèries: | |
| Accés en línia: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|